If you experience persistent nausea, dizziness, or weakness while on combined therapy, contact your PlexusDx provider immediatelythese may signal dose adjustment or discontinuation of one agent
These generally ease as the body adjusts and dosing stabilizes, though ongoing monitoring by a provider is part of responsible GLP-1 treatment
B.WangC.XuZ.NieH.QinX
EFSA J 12(5):3660 Leung AM, Avram AM, Brenner AV, Duntas LH, Ehrenkranz J, Hennessey JV et al (2015) Potential risks of excess iodine ingestion and exposure: statement by the american thyroid association public health committee
To verify if our findings might be extended to other aggressive BC lines independently by UBIAD1 basal expression, we performed similar experiments using the JIMT-1 cell line, a HER2+ human breast cancer cell line with high UBIAD1 expression (Supplementary Fig